DOCSLIB.ORG

Product Safety Data Sheet

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Product Safety Data Sheet Product Safety Data Sheet Document D0001906 Versio 3.0 Code: n: Description: LOTION VELOCE Status: Published Project Veloce Project 08028 Name: Numbe r: Category: Personal Care Segme New Form nt: (Depilatories & Related Products) Formula FILL FORMULA Type: PSDS PSDS 1. PRODUCT AND COMPANY IDENTIFICATION Product Name Veet DepilatoryRapid Action Lotion Hair3 Removalmins Cream Product Type ChemicalChemical Depilatories Depilatories Formulation Reference 00019540001904 - Project Veloce Aloe Vera Extract Variant 0001954 - Project Veloce Silk Extract Varient UPC Codes 62200-76716 Variants Veet DepilatoryVeet Depilatory Lotion Lotion with aloe with vera silk extract Veet Depilatory Lotion with silk extract. Use To removeTo remove unwanted unwanted body body hair hair Appearance MarketedMarketed Product: Product Squeezable: Squeezable plastic plastic tube. tube. Supplier Reckitt Benckiser Depilatory(Canada) Inc.Care R&D, 1680 Tech Avenue Unit #2 DansomMississauga, Lane, ON L4W 5S9 Hull, HU8 7DS, UK Point of Contact in Case of Emergency In TelCase: ++ of44 Emergency:(0) 1482 326151 1-800-888-0192 Transportation Emergencies: 24 Hour Number: North America: Fax: ++ 44 (0) 1482 582532 CHEMTREC: 1-800-424-9300 Technical Services OutsideReckitt North Benckiser America: Depilatory 1-703-527-3887 Care R&D, Dansom Lane, Hull, HU8 7DS, UK. Tel: + 44 (0) 1482 326151 Fax: + 44 (0) 1482 582532 Point of Contact in Case of Emergency Dr Tim Baxter 03/12/2009 17:52:00 GMT Page 1 Product Safety Data Sheet - D0001906 Tel: +44 (0) 1482 582069 2. COMPOSITION Aqua, Urea, Potassium Thioglycolate, Calcium Hydroxide, Cetearyl Alcohol, Ceteareth-20, PPG-15 Stearyl Ether, Potassium Hydroxid Magnesium Trisilicate, Propylene Glycol, Lithium Magnesium Sodium Silicate, Sodium Gluconate, Paraffinum Liquidum, Prunus Amygdalus Dulcis Oil, Acrylate Copolymer, Hydrated Silica, Silk Amino Acids (Silk Variant Only), Aloe Barbadensis (Aloe Vera Variant Only), BHT, Parfum, Citronellol (Silk Varient Only), Hexyl Cinnama Linalool (Silk Varient Only), Butylphenyl Methylpropional, Alpha-Isomethyl Ionone (Aloe Vera Varient Only), Cl 77891. 3. HAZARDS IDENTIFICATION Eye Contact Will cause severe irritation. Skin Contact Prolonged contact may cause chemical burns. Inhalation Not likely in normal use. Ingestion Could cause blistering of the mucous mambrane. 4. FIRST- AID MEASURES Eye Contact Immediately rinse eye for several minutes with plenty of lukewarm water whilst separating the eyelids. Seek medical advice immediately. Skin Contact Cosmetic product designed to be in contact with the skin. In case of accidental and excess application of the product, rinse with plenty of water and seek medical advice if symptoms persist. Inhalation Not an anticipated route of exposure Ingestion Do not induce vomiting. Immediately rinse the mouth with water. Drink one pint (500ml) of water unless there is evidence of burns or difficulty in swallowing. Seek medical advice immediately. 5. FIRE- FIGHTING MEASURES Specific Dangers: The product is not flammable and will not support combustion, i.e. it will not burn. The following hazardous combustion gases may be formed in the event of a fire: carbon. In case of fire, wear self contained breathing apparatus. Extinguisher Type : Any fire extinguisher can be used. 6. ACCIDENTAL RELEASE MEASURES See also Sections 8 and 13. Consumer spillage : Absorb the cream using absorbent material i.e. sand, earth or sawdust and then rinse the affected area with plenty of water or wipe up with a cloth. Rinse hands afterwards with plenty of water. 03/12/2009 17:52:00 GMT Page 2 Product Safety Data Sheet - D0001906 7. HANDLING AND STORAGE Handling Read handling and use instructions carefully. See section 15. Storage Store in a cool frost free place out of the reach of children. Protect from sunlight. Do not expose to temperatures exceeding 40°C. Store preferably between 5°C and 25°C. 8. EXPOSURE CONTROL AND PERSONAL PROTECTION Occupational Exposure Limits Not Applicable Engineering Controls Not Applicable Personal Protective Equipment Not considered as a dangerous product under normal conditions of use. To be used according to the instructions in section 15. 9. PHYSICAL AND CHEMICAL PROPERTIES Appearance White liquid Odour Characteristic to hair removal product pH Alkaline pH< 12.60 at 30°C Density at 20°C between 0.98 and 1.08 10. STABILITY AND REACTIVITY Conditions to Avoid Temperature below 5°C Materials to Avoid Do not let product touch any other materials in case of damage or discoloured. If the product is in contact with any household surface clean immediately. Avoid contact with materials which may be attacked by alkalis. Hazardous Decomposition Products Carbon dioxide and small quantities of sulphur dioxide and dihydrogen sulphide may be produced in the event of a fire. 11. TOXICOLOGICAL INFORMATION See also Section 2 and 3. This product possesses no known toxicological hazards when used as directed and all precautions followed. 12. ECOLOGICAL INFORMATION See also Sections 6,7,13 and 15. 13. DISPOSAL CONSIDERATIONS Consumer Instructions Dispose of empty packaging with normal household waste. Bulk Quantities For further information, contact your local waste authority. (Unsold stock) 14. TRANSPORT INFORMATION Not Classified for transport Local regulations may apply 03/12/2009 17:52:00 GMT Page 3 Product Safety Data Sheet - D0001906 15. REGULATORY INFORMATION The composition, packaging and labelling of this Cosmetic Product for supply in the EU is in accordance with council directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products as amended for the 6th time by council directive 93/35/EEC of 14 June 1993. DIRECTION FOR USE: - Read precautions before use. - Use in an empty bath or shower in order to avoid spillage on carpet, flooring and clothing. - Gently squeeze the lotion directly onto your skin and replace the cap. - Using your hands smooth an even layer of lotion onto the area you wish to treat ensuring the lotion is thick enough to cover the hairs. - Do not rub in. - Wash your hands immediately after application. - Leave the lotion on your skin for 3 minutes timed with a watch. - Then use the sponge to test a small area. If hair comes easily, remove the rest of the lotion by massaging the skin with the sponge under the shower. Rinse thoroughly with lukewarm water. - The time the lotion takes to work depends on the thickness of the hair. - If the hair doesn't come away, leave the lotion on for a bit longer WITHOUT EXCEEDING 8 MINUTES of total application time and remove as detailed above. - Gently pat skin dry and enjoy smoothness that lasts PRECAUTIONS: - Clock icon of Max 8 min. - Follow the direction for use. - Veet 3 Minute Hair Removal Lotion has been designed for legs, underarms and bikini line and can be used anywhere but not on the scalp, face, breast, perianal or genital areas. - Do not use on moles, spotty, broken, irritated or sunburnt skin, or on skin which has been shaved in the last 72 hours or which has suffered an adverse reaction to hair removal creams in the past. - If you use this product for the first time, or on a new body part, ALWAYS TEST YOUR SKIN REACTION by applying the Lotion to a small part of the area you wish to treat, following the directions for use. If after 24 hours there is no adverse reaction, continue to use. - If you experience any smarting/tingling feeling during use, remove the lotion immediately and rinse thoroughly with water. If this sensation persists, seek medical advice. - After use, we recommend waiting 24 hours before applying an anti-perspirant, a perfumed product, or sunbathing. - Take care when using this product as bath surface may become slippery. Clean up any spillage immediately. - Always wait 72 hours between applications. - In case of ingestion, consult a doctor immediately and show the outer pack. - Avoid contact with the eyes. - In case of contact with the eyes, rinse with plenty of water and seek medical advice. - Contains alkali. - Contains thioglycolate. - Keep out of reach of children. 16. OTHER INFORMATION Data sources used in the preparation of this Safety Data Sheet : Raw material supplier's Safety Data Sheets. PSDS # 20581 - Chemical Depilatory Cream/Lotion/Milk Correction of UN Number and Land Packging Group Code. Lotion Veloce (Bulk) PSDS Ref.: D00308022 This document complements the technical usage instructions but does not replace them. The information contained herein is 03/12/2009 17:52:00 GMT Page 4 Product Safety Data Sheet - D0001906 based on our best current technical knowledge of the product concerned, and is given in good faith. The attention of recipients is drawn to (amongst other things) the element of risk consequent to use of the product for a purpose other than that or which it was intended. In no way does this document remove the need of the recipient of the product to fully understand and apply statutory requirements. It is the recipient's sole responsibility to take due precautions relative to the use made of the product. All information contained herein is included only to assist the recipient in fulfilling his or her statutory duty connected with the use of hazardous materials. This list of information must not be considered as exhaustive, and does not exonerate the recipient from taking other precautions described in documents other than those mentioned, concerning the storage and use of the product, for which he or she remains the sole person responsible. Where Used Where Used Customer Product Bill of Material Formulation Bill of Material 62200-76716-00 : VEET,US,LOTN RAPD ACTN 6/200ML 0001954 : FIL,VEET,VELOCE, SILK EXTRACT 0110096 : VEET,CA,LTN RPD 6/200 ML PROM 0064767 : VEET,CA,LTN RPD 6/200 ML TEST 0031093 : VEET,CA,LTN 42/200ML MIX PDQ History Document History (Ver.3.0) Author: David Coates/EUR/R_B Creation Date: 07 Jan 2005 14:10 GMT Creation Reason: New Document Password Validated Signatures Approved By Regulatory: Abigail Ward/EUR/R_B 12 Apr 2005 15:52 GMT Published Date: 12 Apr 2005 15:58 GMT Revision Reason: Update of current PSDS after approval of new template.
Load more

Recommended publications
  • Comparative Study of Shaving and Depilatory Cream for Hair Removal in Inguinal Hernia Surgical Site Preparation
    RESEARCH PAPER Medical Science Volume : 6 | Issue : 2 | FEBRUARY 2016 | ISSN - 2249-555X Comparative Study of Shaving and Depilatory Cream for Hair Removal in Inguinal Hernia Surgical Site Preparation KEYWORDS depilatory cream; shaving; surgical site infection Dr Manish Bansal Gp capt G S Sethi Department of Surgery, Command Hospital (WC), Department of Surgery, Command Hospital (WC), Chandimandir, Panchkula, Haryana, India Chandimandir, Panchkula, Haryana, India ABSTRACT Introduction: Hair interferes with exposure of incision, suturing and wound dressings. Hair removal is thought to reduce the risk of surgical site infections. Three methods of hair removal are used: shaving, clipping and chemical depilation. Aims and objectives: This study aimed to evaluate shaving and depilatory cream for hair removal in inguinal hernia sur- gical site preparation and to compare incidence of surgical site infection, safety, time needed and cost of hair removal. Material and methods: The study was a prospective & comparative study carried out on 100 patients undergoing in- guinal hernia surgical repair at Command Hospital (WC), Chandimandir. Patients were randomized into two groups, i.e., razor shaving group and depilatory cream group. Results: 9 patients (9%) had surgical site infection including 1(2%) in depilatory cream group and 8(16%) in razor group. Infection was significantly associated with razor than depilatory cream. INTRODUCTION There has been no consistent agreement between recom- Postoperative wound infection may lead to significant mendations
    [Show full text]
  • OCTE Safedoc Hairstyling and Aesthetics
    OCTE SAFEdoc H&A Safe Activity Foundations in Education Document (SAFEdoc) Hairstyling and Aesthetics TXJ2O, TXJ3E/4E Also Applicable for Emphasis Courses: TXA3E Hairstyling and Aesthetics: Aesthetics TXH3E Hairstyling and Aesthetics: Hairstyling TXA4E Hairstyling and Aesthetics: Aesthetics TXH4E Hairstyling and Aesthetics: Hairstyling Revision May 2013 This resource was produced by the Ontario Council for Technological Education (OCTE) In support by the Ministry of Education It may be used in its entirety, in part, or adapted. H&A SAFEdoc OCTE SAFEdoc H&A Table of Contents Diclaimer SECTION 1: GENERAL ............................................................................................................ 1 Safe Activity Foundation in Education: Hairstyling & Aesthetics ................................................. 1 Usage of the SAFEdocs ............................................................................................................. 2 Communication .........................................................................................................................12 Safety Expectations ..................................................................................................................13 TXJ2O - Hairstyling And Aesthetics ..........................................................................................13 TXJ3E - Hairstyling And Aesthetics ...........................................................................................13 TXJ4E - Hairstyling And Aesthetics ...........................................................................................14
    [Show full text]
  • A Method to Improve the Efficacy of Topical Eflornithine Hydrochloride Cream
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Drug Deliv Manuscript Author . Author manuscript; Manuscript Author available in PMC 2017 June 01. Published in final edited form as: Drug Deliv. 2016 June ; 23(5): 1495–1501. doi:10.3109/10717544.2014.951746. A method to improve the efficacy of topical eflornithine hydrochloride cream Amit Kumar1, Youssef W. Naguib1, Yan-chun Shi2, and Zhengrong Cui1,2,* 1The University of Texas at Austin, College of Pharmacy, Pharmaceutics Division, Austin, TX 78712 2Inner Mongolia Medical University, Research Center of Molecular Biology, Hohhot, Inner Mongolia, China Abstract Context—Facial hirsutism is a cosmetic concern for women and can lead to significant anxiety and lack of self-esteem. Eflornithine cream is indicated for the treatment of facial hirsutism. However, limited success rate and overall patient’s satisfaction, even with a long-term and high frequency application, leave room for improvement. Objective—The objective of this study is to test the effect of microneedle treatment on the in vitro skin permeation and the in vivo efficacy of eflornithine cream in a mouse model. Materials and method—In vitro permeation study of eflornithine was performed using Franz diffusion cell. In vivo efficacy study was performed in a mouse model by monitoring the re-growth of hair in the lower dorsal skin of mice after the eflornithine cream was applied onto an area pretreated with microneedles. The skin and the hair follicles in the treated area were also examined histologically. Results and discussion—The hair growth inhibitory activity of eflornithine was significantly enhanced when the eflornithine cream was applied onto a mouse skin area pretreated with microneedles, most likely because the micropores created by microneedles allowed the permeation of eflornithine into the skin, as confirmed in an in vitro permeation study.
    [Show full text]
  • CLINICAL EVALUATION of HANDHELD SELF-TREATMENT DEVICE for HAIR REMOVAL James M
    788 COPYRIGHT © 2007 JOURNAL OF DRUGS IN DERMATOLOGY CLINICAL EVALUATION OF HANDHELD SELF-TREATMENT DEVICE FOR HAIR REMOVAL James M. Spencer MD Spencer Dermatology and Skin Surgery, St. Petersburg, FL Abstract Background and Objectives: Laser and light-based methods for hair removal, though effective, are expensive and may be associated with adverse effects. Our objective was to evaluate the efficacy and safety of a thermal, handheld self-treat- ment device (no!no!™ Thermicon™, Radiancy Inc, Orangeburg, NY) for removing unwanted hair. Methods: Twelve of the 20 enrolled subjects underwent 6 supervised and 6 unsupervised self-treatments of their lower legs and umbilicus-bikini areas at twice-weekly intervals for 6 weeks. Follow-up visits were scheduled at 2, 6, and 12 weeks after the final treatment. Results were evaluated by pretreatment, post-treatment, and follow-up hair counts. Results: For legs, the median clearance percentages were 48% post-treatment and 43.5% at 12 weeks. For the umbili- cus-bikini area, the median clearance percentage was 15.0 % at 12 weeks. Conclusions: The efficacy and safety of the no!no! Thermicon device for hair removal of the legs appear to be compa- rable to those of laser devices. Introduction a thermal mechanism. The hair is heated, the heat is con- Traditional hair-removal methods such as waxing, shaving, ducted to the hair follicle, and the follicle is destroyed by heat. and chemical depilatory treatments are often inconvenient. Removing hair with laser or light-based treatments is expen- Permanent methods such as electrolysis are painful, expen- sive and requires multiple visits to medical clinics or spas.
    [Show full text]
  • Primary Generalized and Localized Hypertrichosis in Children
    STUDY Primary Generalized and Localized Hypertrichosis in Children Roopal A. Vashi, MD; Anthony J. Mancini, MD; Amy S. Paller, MD Objective: To review the causes, presentation, and sets of hypertrichosis cubiti, anterior cervical hypertri- therapy of primary generalized and localized symmetri- chosis, posterior cervical hypertrichosis, and faun tail cal hypertrichosis in children. deformity. All patients with generalized hypertrichosis manifested the condition at birth; the age of onset in chil- Design: Retrospective medical record review. dren with localized symmetrical primary hypertrichosis ranged from birth to 4 years. One girl with generalized Setting: Academic specialty referral clinic for pediatric hypertrichosis had gingival hyperplasia and the girl with dermatological disorders. faun tail deformity had bony diastematomyelia with spina bifida occulta. The medical histories and physical ex- Patients: Case series of 11 prepubertal male and fe- amination findings of all of the children were otherwise male patients who had idiopathic hypertrichosis be- unremarkable. All patients were referred for diagnostic tween July 1, 1990, and November 30, 1999. and therapeutic considerations. Interventions: None. Conclusions: Primary hypertrichotic conditions, whether localized or generalized, are rare in pediatric patients and Main Outcome Measures: Clinical distribution of in- of unknown origin. Although otherwise benign, these dis- creased hair growth and types of hair removal methods orders may result in cosmetic disfigurement and psy- used. chosocial trauma for patients and families. Patients and their families should be adequately advised of the avail- Results: Seven girls and 4 boys, ranging in age from 4 able treatment methods for both temporary and perma- months to 11 years, were evaluated. Four patients showed nent hair removal.
    [Show full text]
  • Use of Chemical Depilatory Agents on Laboratory Animals the University of Texas at Austin Institutional Animal Care and Use Committee
    Guidelines for the Use of Chemical Depilatory Agents on Laboratory Animals The University of Texas at Austin Institutional Animal Care and Use Committee These guidelines have been written to assist faculty, staff, and students in performing vertebrate animal procedures in a humane manner and complying with pertinent regulatory requirements. Under some circumstances deviations from these procedures may be indicated but such variances must be approved in advance by the IACUC. This document provides information to researchers who use chemical depilatory agents in order to remove hair on animals used for research, teaching, or other purposes at the University of Texas at Austin. It is organized into three sections: Section A – Background Information Section B – Use of Chemical Depilatory Agents Section C – References and Acknowledgements Section A – Background Information Chemical depilatory agents (e.g. Nair, Veet, etc.) may be used on animals designated for IACUC approved procedures, including but not limited to surgery, imaging, blood collection, or routine cleaning of cranial implants. An advantage of using a depilatory is its ease of use in areas that are difficult to shave; however, researchers should take precautions when using depilatories in order to ensure the health and well-being of the animal. Application of depilatories should be in accordance with the manufacturer’s directives. Section B – Use of Chemical Depilatory Agents Appropriate hair removal is often best performed when the animal is anesthetized, although that is not always possible. In the instance that the animal cannot be anesthetized, it should be properly restrained. The depilatory may be applied directly to the animal’s hair/fur, or the researcher may shave or clip the area of interest prior to application.
    [Show full text]
  • Evaluation of Patient Satisfaction After Treatment with the Alexandrite Laser for Hirsutism
    ORIGINAL ARTICLE Evaluation of patient satisfaction after treatment with the alexandrite laser for hirsutism Farideh Jowkar, MD 1,2 Background: Laser treatment is a rapid, non-invasive procedure for Najmeh Radgoodarz, MDi 3 long-term hair removal. Lasers operate based on the principle of Nasrin Saki, MD 1,2 selective photothermolysis and target melanin in the hair follicle. We intend to determine the level of hirsute patient satisfaction Alireza Heiran 4 with the alexandrite laser hair removal procedure. 1. Molecular Dermatology Research Methods: In this cross-sectional study 82 hirsute patients with Center, Shiraz University of Medical unwanted hair on their faces were enrolled. The patients received Sciences, Shiraz, Iran treatment with a 755 nm alexandrite laser (GentleLASE, Candela 2. Department of Dermatology, Shiraz Corporation, USA). We documented their level of satisfaction with University of Medical Sciences, this laser in terms of hair removal. Laser therapy, electrolysis, Shiraz, Iran and depilation were compared. 3. Department of Internal Medicine, Tehran University of Medical Results: Patients ≥30 years old expressed greater satisfaction Sciences, Tehran, Iran compared to those <30 years of age (P=0.03). Patients with medically 4. Student Research Committee, related hirsutism had the same satisfaction as the idiopathic Shiraz University of Medical hirsute group (P=0.81). Patients rated laser hair removal as 4.12 Sciences, Shiraz, Iran compared to depilation and 3.96 compared to electrolysis. From total patients, 60.97% would recommend laser treatment to other Corresponding Author: hirsute patients. There were 79.3% of patients who expressed Nasrin Saki, MD satisfaction with alexandrite laser hair removal.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2002/0128522 A1 Te0doro Et Al
    US 2002O128522A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2002/0128522 A1 Te0doro et al. (43) Pub. Date: Sep. 12, 2002 (54) PROCESS FOR THE PREPARATION OF 4.4 (30) Foreign Application Priority Data -DHALOGEN-O-HYDROXYDIPHENYL COMPOUNDS Oct. 6, 1998 (EP)........................................ 988 11 OO2.9 Publication Classification (76) Inventors: Armando Di Teodoro, Rheinfelden (51) Int. Cl." ..................................................... C07C 43/20 (DE); Werner Holzl, Eschentzwiller (52) U.S. Cl. .............................................................. 568/637 (FR); Dieter Reinehr, Kandern (DE); Rudolf Zink, Therwil (CH) (57) ABSTRACT Disclosed is a four-step proceSS for the preparation of Correspondence Address: 4,4'-dihalogen-O-hydroxydiphenyl compounds of formula CBA SPECIALTY CHEMICALS CORPORATION (1) PATENT DEPARTMENT OH 540 WHITE PLAINS RD PO BOX 2005 TARRYTOWN, NY 10591-9005 (US) Hal Hall, (21) Appl. No.: 10/137,791 (22) Filed: May 2, 2002 by halogenation of a diphenyl compound (step 1a) or by the reaction of p-halophenol and p-dihalobenzene (step 1b), Related U.S. Application Data acylation of the dihalogen compound in a Friedel-Crafts (63) Continuation of application No. 09/806,359, filed on reaction (2"step), oxidation of the acyl compound (3"step) Mar. 29, 2001, now abandoned, filed as 371 of and hydrolysis (4" step). international application No. PCT/EP99/07158, filed The compounds of formula (1) are used for protecting on Sep. 27, 1999. organic materials and objects from microorganisms. US 2002/O128522 A1 Sep. 12, 2002 PROCESS FOR THE PREPARATION OF 4.4 -DHALOGEN-O-HYDROXYDIPHENYL -continued COMPOUNDS 0001. The present invention relates to a process for the OH preparation of 4,4'-dihalogen-O-hydroxy-diphenyl com pounds of formula (1) OH Cl C O (3) Hal Hall, 0006) However, the yield obtained by this method of 0002 wherein preparation is unsatisfactory as different chemical reactions 0003 Hal is a halogen atom, may take place concurrently.
    [Show full text]
  • Original Article Evaluation of Two Methods of Preoperative Hair
    Original Article Evaluation of two methods of preoperative hair removal and their relationship to postoperative wound infection Adewale O. Adisa, Olukayode O. Lawal, Olusanya Adejuyigbe Department of Surgery, Obafemi Awolowo University, Ile-Ife, Nigeria Abstract Introduction: When a surgical operation is to be conducted through a hair bearing part of the body, hair removal is often performed. This study aimed to evaluate the relationship of two methods of preoperative hair removal to postoperative wound infection in a developing country where razor shaving is very popular. Methodology: Consecutive consenting patients scheduled to have such operations were randomized into two groups. One group had hair removal by shaving with a razor blade while the other had hair removed by depilatory cream. Adequacy of hair removal and presence of skin injuries and/or reactions were noted preoperatively. Details of the procedures were recorded and patients were then assessed for postoperative wound infection. Results: A total of 165 patients were studied. Of the 79 patients who had hair removal by depilatory cream, hair was completely removed in 70 (88.6%) compared to 53 (61.6%) of the 86 patients who had razor hair shaving (p < 0.0001). Skin injuries were noted in 24 (27.9%) of the razor group and 3 (3.8%) of patients who had depilatory cream, (p = 0.001). Thirteen patients (7.9%) had postoperative wound infection including 2 (2.5%) in the depilatory cream group and 11 (12.8%) of the razor group. A significant association was found between preoperative skin injuries and postoperative wound infections. Conclusion: Preoperative hair removal with razor shaving predisposes to skin injuries which in turn significantly influence postoperative wound infection rates.
    [Show full text]
  • Hypertricosis Not Uncommon After Laser Removal of Facial Hair
    48 Dermatologic Surgery S KIN & ALLERGY N EWS • June 2007 Hypertricosis Not Uncommon For Hidradenitis After Laser Removal of Facial Hair Suppurativa, Hair Removal Aids Tx ARTICLES BY laser or intense pulsed light. They re- Several dermatologists who heard MITCHEL L. ZOLER ceived 3-23 treatments. the report at the meeting said that G RAPEVINE, TEX — Hair removal by intense Philadelphia Bureau At follow-up, an average of 10% of their own anecdotal experience con- pulsed light is a useful adjunctive treatment for re- the women had increased facial hair, firmed Dr. Willey’s report. fractory hidradenitis suppurativa, based on experi- G RAPEVINE, TEX. — Facial-hair 8% had no change, 78% had reduced “You can predict which women will ence with 10 patients at one center. removal with laser energy can back- hair growth, and 3% had complete have this. They all have fine, almost Five of the treated patients had clear improvement fire and trigger hypertrichosis if the hair removal. The remaining 1% had downy hair on dark skin that is type in their clinical status after 3-4 hair-removal treat- regimen is not optimized, Dr. An- incomplete information and weren’t III or higher,” said Dr. Jeffrey S. Dover, ments, with reduced or resolved lesions in the treat- drea Willey said at the annual meet- included in the analysis. a dermatologist in private practice in ed area. The remaining five patients had improvement ing of the American Society for Laser Women with hypertrichosis after Chestnut Hill, Mass. after four to eight treatments, Dr. Agneta Troilius said Medicine and Surgery.
    [Show full text]
  • ANNEX II: Frame Formulations
    ANNEX II: Frame formulations FRAME FRAME FORMULATION NAME FORMULATION NUMBER 1. SKIN CARE SKIN CARE CREAM, LOTION, GEL 1.1 SKIN CARE CREAM, LOTION, GEL - WITH HIGH LEVEL OF SILICONES 1.2 SKIN CARE CREAM, LOTION, GEL - WITH HIGH LEVEL OF HUMECTANTS 1.3 SKIN CARE CREAM, LOTION, GEL - WITH HIGH LEVEL OF BULKING AGENTS 1.4 SKIN CARE CREAM, LOTION, GEL - WITH HIGH LEVEL OF FATTY COMPOUNDS 1.5 SKIN CARE CREAM, LOTION, GEL - WITH HIGH LEVEL OF UV FILTERS 1.6 SKIN CARE CREAM, LOTION, GEL – WITH HIGH LEVEL OF PERFUME 1.7 ZINC OXIDE BASED CREAM 1.8 SKIN GEL (HYDRO-ALCOHOLIC BASED) 1.9 SKIN OIL 1.10 TONIC, COSMETIC WATER 1.12 CHEMICAL EXFOLIATION PRODUCTS 1.13 SKIN CARE (SILICONE BASED) 1.14 PETROLEUM JELLY 1.15 1 TALCUM POWDER (LOOSE OR PRESSED) 1.16 LIP CARE (STICK, CREAM, GEL) 1.17 2. SKIN CLEANSING FOAMING SKIN CLEANSER 2.1 FOAMING SKIN CLEANSER – WITH HIGH LEVEL OF OILS AND/OR HUMECTANT 2.2 MAKE-UP REMOVER - NON FOAMING CLEANSER (INCLUDING TWO-PHASE 2.3 PRODUCTS) MAKE-UP REMOVER - NON FOAMING OIL CLEANSER 2.4 GENTLE CLEANSING GEL 2.5 SKIN CLEANSING CREAM, LOTION, SCRUB, GEL 2.6 BODY SCRUB (GEL, CREAM) 2.7 SOAP – TOILET 2.8 LIQUID SOAP 2.9 BATH AND SHOWER GEL, CREAM, MILK, PASTE 2.10 SLIGHTLY FOAMING SHOWER CREAM, MILK 2.11 BATH SALTS / CUBES 2.12 BATH AND SHOWER OIL (INCLUDING BATH BEADS) 2.13 FOOTBATH 2.14 SYNDET BAR 2.15 COMBO BAR 2.16 2 3. HAIR REMOVAL CHEMICAL DEPILATORY – CREAM, GEL 3.1 PHYSICAL DEPILATORY WAX – RESIN BASED 3.2 PHYSICAL DEPILATORY WAX – SUGAR BASED 3.3 4.
    [Show full text]
  • The Evolution of Hair Removal SPONSORE D CONTE NT Did You Know Cosmetic January 5, 2011 Terri Wojak Lasers Can Double Your January 2011 Issue of Skin Inc
    T R E AT ME NT S > H AI R R E MO V AL The Evolution of Hair Removal SPONSORE D CONTE NT Did You Know Cosmetic January 5, 2011 Terri Wojak Lasers Can Double Your January 2011 issue of Skin Inc. magazine Income? — National Laser Institute All About Meridian Massage for Facial Rejuvenation (VIDEO) — PurErb Skincare History demonstrates that hair removal methods have been around for a long time. When most people think of evolution, they automatically picture a hairy caveman; however, hair removal has been around since the Stone A Natural Alternative to Age, approximately 10,000 BC, from which there are ancient paintings Harsh Scrubs — Circadia showing cavemen using two seashells as tweezers. by Dr. Pugliese As far back as 30,000 BC, flint, a hard form of mineral quartz with sharp edges, was used as a shaving device. Technology has come a long way A D V ER T IS EM ENT since then. One example is laser hair removal systems that have been developed to permanently reduce the amount of hair that grows. According to the American Society of Aesthetic Plastic Surgery, laser hair removal is the third most popular nonsurgical cosmetic procedure performed in the United States,and according to www.​surgery.​org, the organiza​tion’s website, there were 1,280,031 laser hair removal procedures performed in 2009. Even though hair removal has evolved since the Stone Age, it still has a long way to go. New devices are constantly being developed that are more effective and easier to use than what was available as recently as several years ago.
    [Show full text]